Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system

被引:45
作者
Hashimoto, K [1 ]
Nishiyama, M [1 ]
Tanaka, Y [1 ]
Noguchi, T [1 ]
Asaba, K [1 ]
Hossein, PN [1 ]
Nishioka, T [1 ]
Makino, S [1 ]
机构
[1] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi 7838505, Japan
关键词
urocortin I; urocortin II; urocortin III; CRF type 2 receptor; VMH; PVN; stress;
D O I
10.1016/j.peptides.2004.05.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In addition to urocortin (Ucn I), Ucn II and Ucn III were identified as endogenous ligands for corticotropin-releasing factor type 2 receptor (CRF2 receptor). CRF2 receptor is abundantly located in central hypothalamic ventromedial nucleus (VMH) and in peripheral cardiovascular system. In this mini-review, we focused on the roles of these urocortins and CRF2 receptor in the hypothalamus and the cardiovascular system. Ucn II mRNA was increased in the parvocellular part or the magnocellular part of the hypothalamic paraventricular nucleus (PVN) following immobilization stress or 3 days of water deprivation, respectively. Therefore, it is thought that Ucn II may modulate CRF and vasopressin synthesis in the PVN in a paracrine or autocrine fashion through PVN CRF2 receptor. The early and later phases of Ucn I-mediated feeding suppression may be CRF1 and CRF2 receptor-mediated events, respectively. Ucn II decreases food intake at a later phase, beyond 4 h post injection. A large dose of corticosterone increased plasma leptin and insulin levels as well as the levels of CRF2 receptor mRNA. Adrenalectomy, starvation, and immobilization each lowered plasma leptin and insulin levels and were associated with decrements in CRF2 receptor mRNA levels in the VMH. Peripheral injection of leptin increased VMH CRF2 receptor mRNA, as can induce reductions of food intake and body weight, indicating that circulating leptin is involved in the regulation of VMH CRF2 receptor mRNA expression. Therefore, it is also plausible that VMH CRF2 receptor transduces the anorexogenic effects of leptin as well as those of urocortins. The systemic administration of Ucn II decreases mean arterial pressure (arterial vascular tone) and causes tachycardia via vascular CRF2 receptor in rats, similar to the effects of Ucn I. Thus, CRF2 receptor seems to mediate cardioprotective effects of urocortins. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1711 / 1721
页数:11
相关论文
共 92 条
[1]   Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for type-1 andType-2 corticotropin-releasing hormone receptors [J].
Arima, H ;
Aguilera, G .
JOURNAL OF NEUROENDOCRINOLOGY, 2000, 12 (09) :833-842
[2]   Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone [J].
Asaba, K ;
Makino, S ;
Hashimoto, K .
BRAIN RESEARCH, 1998, 806 (01) :95-103
[3]   Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin [J].
Asaba, K ;
Makino, S ;
Nishiyama, M ;
Hashimoto, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) :493-497
[4]   Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold [J].
Bale, TL ;
Anderson, KR ;
Roberts, AJ ;
Lee, KF ;
Nagy, TR ;
Vale, WW .
ENDOCRINOLOGY, 2003, 144 (06) :2580-2587
[5]   Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior [J].
Bale, TL ;
Picetti, R ;
Contarino, A ;
Koob, GF ;
Vale, WW ;
Lee, KF .
JOURNAL OF NEUROSCIENCE, 2002, 22 (01) :193-199
[6]   Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress [J].
Bale, TL ;
Contarino, AB ;
Smith, GW ;
Chan, R ;
Gold, LH ;
Sawchenko, PE ;
Koob, GF ;
Vale, WW ;
Lee, KF .
NATURE GENETICS, 2000, 24 (04) :410-414
[7]  
Bittencourt JC, 1999, J COMP NEUROL, V415, P285
[8]   Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice [J].
Bradbury, MJ ;
McBurnie, MI ;
Denton, DA ;
Lee, KF ;
Vale, WW .
ENDOCRINOLOGY, 2000, 141 (08) :2715-2724
[9]   Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart [J].
Brar, BK ;
Jonassen, AK ;
Egorina, EM ;
Chen, A ;
Negro, A ;
Perrin, MH ;
Mjos, OD ;
Latchman, DS ;
Lee, KF ;
Vale, W .
ENDOCRINOLOGY, 2004, 145 (01) :24-35
[10]   CORTICOTROPIN-RELEASING FACTOR RECEPTOR ANTAGONIST - EFFECTS ON THE AUTONOMIC NERVOUS-SYSTEM AND CARDIOVASCULAR FUNCTION [J].
BROWN, MR ;
GRAY, TS ;
FISHER, LA .
REGULATORY PEPTIDES, 1986, 16 (3-4) :321-329